OriliTM

Elagolix
Endometriosis Management (Hormone Preparation)

Indication:
OriliTM 150 tablet is indicated for the management of moderate to severe endometriosis pain with or without moderate hepatic impairment.
OriliTM 200 tablet is indicated for the management of moderate to severe pain associated with endometriosis.

Dosage & Administration:
Pregnancy should be excluded before starting treatment with elagolix and start elagolix within 7 days from the onset of menses.
OriliTM 150 tablet: Initial treatment with Elagolix 150 mg once daily up to 24 months. But, in case of moderate hepatic impairment, up to 6 months treatment is recommended.
OriliTM 200 tablet: Initial treatment with elagolix 200 mg twice daily up to 6 months (with coexisting dyspareunia). Treatment with elagolix 200 mg should not exist more than 6 months as it may decrease bone mineral density (BMD). In case of moderate to severe hepatic impairment elagolix 200 mg is not recommended.

Preparation:
OriliTM 150 tablet: Each box contains 12 tablets in Alu-Alu blister pack.
OriliTM 200 tablet: Each box contains 12 tablets in alu-alu blister strip.



  • Products By Trade Name

  • Products By Generic

  • Products By Therapeutic Class

  • Herbal & Nutraceuticals

  • AgroVet & Pesticides